Couverture de Malignant

Malignant

Black Market DNA, Book 2

Aperçu

30 jours d'essai gratuit à Audible Standard

Essayer Standard gratuitement
Choisissez 1 livre audio par mois dans l'ensemble de notre catalogue.
Écoutez les livres audio que vous avez choisis pendant toute la durée de votre abonnement.
Accédez à volonté à des podcasts incontournables.
Gratuit avec l'offre d'essai, ensuite 2,99 €/mois. Possibilité de résilier l'abonnement chaque mois.

Malignant

De : Anthony J. Melchiorri
Lu par : Bradford Hastings
Essayer Standard gratuitement

Renouvellement automatique à 2,99 € mois après 30 jours. Annulation possible chaque mois.

Acheter pour 17,91 €

Acheter pour 17,91 €

À propos de ce contenu audio

Sometimes medical science can take lives just as easily as it can save them.

A genetically engineered and unstoppable cancer is spreading through Baltimore’s citizens. Doctor Robin Haynes is used to dealing firsthand with this unforgiving disease, but when every medical tool at her disposal fails, she becomes desperate for a cure.

Christopher Morgan is a former illegal genetic enhancement dealer. After paying for his crimes, he’s devoted himself to developing genetic therapies to save lives. He eagerly joins Robin on a quest to engineer a treatment.

As the cancer spreads across the country, Robin and Chris discover the disease may be connected to a criminal organization. With the body count rising, they find themselves embroiled in something deeper than they ever imagined — an underground world of scientific intrigue, organized crime, and medical conspiracies.

They set out to save lives, but now they might lose theirs in the process.

Malignant is Book two in the Black Market DNA series. While each book in this medical mystery-thriller series can be listened to as a stand alone, the chronological order is: Enhancement (Book 1), Malignant (Book 2), Variant (Book 3)

©2020 Anthony J. Melchiorri (P)2020 Anthony J. Melchiorri
Aventure Fiction Médical Médico-légal Science-fiction Thrillers et romans à suspense
Aucun commentaire pour le moment